Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethyl EPA in Bipolar Depression
NCT04811404Phase 4Withdrawn
- Sponsor
- New York State Psychiatric Institute
- Start
- Mar 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omega-3-acid triglycerides in bipolar disorder (BD), sponsored by New York State Psychiatric Institute. Planned start Mar 2021; status: withdrawn.
02
Drugs
omega-3-acid triglycerides
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT04811404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04811404.